The Problem With Composite End Points in Cardiovascular Studies

Kip, Kevin E., Hollabaugh, Kim, Marroquin, Oscar C., Williams, David O.·2008·Journal of the American College of Cardiology

Cited by (348)

Items 101–200 of 348

  1. Thrombolysis for acute upper extremity deep vein thrombosis
    Joshua Buron Feinberg, Emil Eik Nielsen, Janus Christian Jakobsen · 2017 · Cochrane Database of Systematic Reviews
  2. Telomere Length and Risk of Major Adverse Cardiac Events and Cancer in Obstructive Sleep Apnea Patients
    Katarzyna Polonis, Sreeja Sompalli, Christiane Becari, Jiang Xie, Naima Covassin, Phillip J. Schulte, Brooke R. Druliner, Ruth Johnson, Krzysztof Narkiewicz, Lisa A Boardman et al. · 2019 · Cells
  3. Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop
    Emma O’Lone, Andrea Katharina Viecelli, Jonathan C. Craig, Allison Tong, Bénédicte Sautenet, William Guy Herrington, Charles A. Herzog, Tazeen H. Jafar, Meg Jardine, Vera Krane et al. · 2020 · American Journal of Kidney Diseases
  4. Benefit-Risk Evaluation and Decision Making: Some Practical Insights
    Michael W. Colopy, ChandrasekharRao Venkata Damaraju, Weili He, Qi Jiang, Bennett S. Levitan, Shiling Ruan, Žhong Yuan · 2015 · Therapeutic Innovation & Regulatory Science
  5. Introducing the Tehran Heart Center's Premature Coronary Atherosclerosis Cohort: THC-PAC Study.
    Seyed Hesameddin Abbasi, Seyed Ebrahim Kassaian, Saeed Sadeghian, Abbasali Karimi, Soheil Saadat, Flora Peyvandi, Arash Jalali, Tahereh Davarpasand, Nazila Shahmansouri, Masoumeh Lotfi‐Tokaldany et al. · 2015 · PubMed Central
  6. Association of Race and Major Adverse Cardiac Events (MACE): The Atherosclerosis Risk in Communities (ARIC) Cohort
    Ericha G. Franey, Donna C. Kritz‐Silverstein, Erin Richard, John E. Alcaraz, Caroline M. Nievergelt, Richard A. Shaffer, Vibha Bhatnagar · 2020 · Journal of Aging Research
  7. Alcohol Intake More than Doubles the Risk of Early Cardiovascular Events in Young Hypertensive Smokers
    Paolo Palatini, Claudio Fania, Lucio Mos, Adriano Mazzer, Francesca Saladini, Edoardo Casiglia · 2017 · The American Journal of Medicine
  8. Oral Health and Cardiovascular Disease: Mapping Clinical Heterogeneity and Methodological Gaps
    Musfer Aldossri, Julie W. Farmer, Olli Saarela, Laura C. Rosella, Carlos Quiñonez · 2020 · JDR Clinical & Translational Research
  9. Hierarchical testing of composite endpoints: applying the win ratio to percutaneous coronary intervention versus coronary artery bypass grafting in the SYNTAX trial
    Milan Milojevic, Stuart J. Head, Eleni‐Rosalina Andrinopoulou, Patrick W.J.C. Serruys, Friedrich Wilhelm Mohr, Jan G.P. Tijssen, A. Pieter Kappetein · 2017 · EuroIntervention
  10. Association between inflammatory cytokines and long-term adverse outcomes in acute coronary syndromes: A systematic review
    Gisela A. Kristono, A. Holley, Prashant Lakshman, Morgane M. Brunton-O’Sullivan, Scott A. Harding, Peter Larsen · 2020 · Heliyon
  11. SEA-MAKE score as a tool for predicting major adverse kidney events in critically ill patients with acute kidney injury: results from the SEA-AKI study
    Theerapon Sukmark, Nuttha Lumlertgul, Kearkiat Praditpornsilpa, Kriang Tungsanga, Somchai Eiam‐Ong, Nattachai Srisawat · 2020 · Annals of Intensive Care
  12. Identifying Patients with Low Risk of Acute Coronary Syndrome Without Troponin Testing: Validation of the HEAR Score
    Thomas Moumneh, Benjamin Sun, Aileen S. Baecker, Stacy Park, Rita F. Redberg, Maros Ferencik, Mingsum S Lee, Delphine Douillet, Pierre‐Marie Roy, Adam L. Sharp · 2020 · The American Journal of Medicine
  13. Cardiovascular risk of Janus kinase inhibitors compared with biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis without underlying cardiovascular diseases: a nationwide cohort study
    Yun‐Kyoung Song, Gaeun Lee, Jinseub Hwang, JW Kim, Jin‐Won Kwon · 2023 · Frontiers in Pharmacology
  14. Major cardiovascular events in patients with cardiovascular monosodium urate deposits in atherosclerotic plaques
    Julia Held, Christoph Schwabl, David Haschka, Sarah Christine Maier, Gudrun Maria Feuchtner, Gerlig Widmann, Christina Duftner, Günter Weiß, Andrea Sabine Klauser · 2024 · Rheumatology
  15. Is lipid goal one-size-fits-all: A review of evidence for recommended low-density lipoprotein treatment targets in Asian patients
    Yun Wang, Bryan P. Yan, Brian Tomlinson, Vivian Wing Yan Lee · 2019 · European Journal of Preventive Cardiology
  16. Cardiovascular events associated with nicorandil administration prior to primary percutaneous coronary intervention in patients with acute ST-segment elevated myocardial infarction: a systematic review and meta-analysis
    Jiaying Li, Xiaoming Xu, Xinbin Zhou, Jin Ming Dai, Lan Ma, Chen Chen, Xinyao Li, Wei Mao · 2019 · Expert Opinion on Drug Safety
  17. Comparison of usual care and the HEART score for effectively and safely discharging patients with low‐risk chest pain in the emergency department: would the score always help?
    Guangmei Wang, Wen Zheng, Shuo Wu, Jingjing Ma, He Zhang, Jiaqi Zheng, Jiali Wang, Feng Xu, Yuguo Chen · 2019 · Clinical Cardiology
  18. Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure
    Claire Mac Sweeney, Fiona Ryan, Mark T. Ledwidge, Cristín A. Ryan, Kenneth McDonald, Chris J Watson, Rebabonye B. Pharithi, Joe Gallagher · 2019 · Cochrane Database of Systematic Reviews
  19. The association between recent hospitalized COPD exacerbations and adverse outcomes after percutaneous coronary intervention: a nationwide cohort study
    Wei‐Chieh Lin, Chang-Wen Chen, Chin‐Li Lu, Wu‐Wei Lai, Min‐Hsin Huang, Liang-Miin Tsai, Chung‐Yi Li, Chao‐Han Lai · 2019 · International Journal of COPD
  20. Endpoint Selection and Relative (Versus Absolute) Risk Reporting in Published Medication Trials
    Michael E. Hochman, Danny McCormick · 2011 · Journal of General Internal Medicine
  21. Impact of phase angle and sarcopenia estimated by bioimpedance analysis on clinical prognosis in patients undergoing hemodialysis
    Eunjin Bae, Tae Won Lee, Wooram Bae, Seongmin Kim, Jungyoon Choi, Ha Nee Jang, Se‐Ho Chang, Dong Jun Park · 2022 · Medicine
  22. Induction immunosuppression agents as risk factors for incident cardiovascular events and mortality after kidney transplantation
    Shaifali Sandal, Sunjae Bae, Mara McAdams‐DeMarco, Allan B. Massie, Krista L. Lentine, Marcelo Cantarovich, Dorry Lidor Segev · 2018 · American Journal of Transplantation
  23. Left Ventricular Function and Myocardial Triglyceride Content on 3T Cardiac MR Predict Major Cardiovascular Adverse Events and Readmission in Patients Hospitalized with Acute Heart Failure
    Kuang-Fu Chang, Gigin Lin, Pei-Ching Huang, Yu‐Hsiang Juan, Chao‐Hung Wang, Shang‐Yueh Tsai, Yu‐Ching Lin, Ming‐Tsang Wu, Pen-An Liao, Lan‐Yan Yang et al. · 2020 · Journal of Clinical Medicine
  24. What is the effect of electronic clinical handovers on patient outcomes? A systematic review
    Belinda Delardes, Lisa McLeod, Samantha Paubrey Chakraborty, Kelly‐Ann Bowles · 2020 · Health Informatics Journal
  25. Comprehensive review of statin-intolerance and the practical application of Bempedoic Acid
    Siva Naga S. Yarrarapu, Amandeep Goyal, Vikramaditya Samala Venkata, Viraj S. Panchal, Barath Prashanth Sivasubramanian, Doantrang T. Du, Roopesh Sai Jakulla, Hema Pamulapati, Mazhar A. Afaq, Steven Owens et al. · 2024 · Journal of Cardiology
  26. Global Outcome in Patients With Left Ventricular Assist Devices
    Timothy J. Fendler, Michael E. Nassif, Kevin F. Kennedy, Susan M Joseph, Scott Silvestry, Gregory Alan Ewald, Shane LaRue, Justin M. Vader, John A. Spertus, Suzanne V. Arnold · 2017 · The American Journal of Cardiology
  27. Major Acute Cardiovascular Events After Transurethral Prostate Surgery: A Population-based Analysis
    Michele Marchioni, Luca Cindolo, Marta Di Nicola, Luigi Schips, Marco DE SIO, Estêvão Lima, Vincenzo G. Mirone, Luigi Cormio, EVANGELOS N. LIATSIKOS, Francesco Porpiglia et al. · 2019 · Urology
  28. Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005–2016
    Iiro Toppila, Kai Kysenius, Tatu A. Miettinen, Mariann Ida Lassenius, Juha Lievonen, Pekka M. Anttila · 2022 · Annals of Hematology
  29. Diabetic patients with normal baseline renal function are at increased risk of developing contrast-induced nephropathy post-percutaneous coronary intervention.
    Eric Y. Chong, Kian Keong Poh, Linghong Shen, Ping Chai, Hua Tan · 2009 · PubMed
  30. Chasing myocardial outcomes: perioperative myocardial infarction and cardiac troponin
    Marc B. Royo, Lee A. Fleisher · 2015 · Canadian Journal of Anesthesia/Journal canadien d anesthésie
  31. Predictive potential of biomarkers and risk scores for major adverse cardiac events in elderly patients undergoing major elective vascular surgery
    Velimir Perić, Mlađjan Golubović, Milan Lazarević, Tomislav L. Kostić, Dragana Stokanović, Miodrag N. Đorđević, Vesna Marjanović, Marija D. Stošić, Dragan J. Milić · 2021 · Reviews in Cardiovascular Medicine
  32. Cost‐effectiveness of percutaneous coronary intervention with drug‐eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five‐years after intervention
    Lisa Krenn, Christoph W. Kopp, Dietmar Glogar, Irene Marthe Lang, Georg Delle‐Karth, Thomas Neunteufl, Gerhard Kreiner, Alexandra Kaider, Jutta K Bergler-Klein, Aliasghar Khorsand et al. · 2014 · Catheterization and Cardiovascular Interventions
  33. CHA2DS2‐VASc scores predict major adverse cardiovascular events in patients with chronic obstructive pulmonary disease
    Hean Ooi, Li‐Hsiou Chen, Yung‐Lun Ni, Huan‐Ting Shen, Yen‐Hsien Lee, Yi‐Chun Chu, Ke‐Chih Fang, I‐Hung Chen, Shu‐Lan Hsu, Hsing‐Chun Chen et al. · 2017 · The Clinical Respiratory Journal
  34. Use and misuse of composite endpoints in randomised clinical trials
    Joan Siquier-Padilla, Rafael González Manzanares, Xavier Rosselló · 2025 · Heart
  35. Long-term Outcomes for Drug-eluting Balloons versus Drug-eluting Stents in the Treatment of Small Vessel Coronary Artery Disease: A Systematic Review and Meta-analysis
    Greg Murphy, Ailish Naughton, Rory Durand, Elizabeth A. Heron, C McCaughey, Ross T. Murphy, Ian R. Pearson · 2023 · Interventional Cardiology Reviews Research Resources
  36. Use of troponin to diagnose periprocedural myocardial infarction: effect on composite endpoints in the British Bifurcation Coronary Study (BBC ONE)
    James Cockburn, Miles Behan, Adam de Belder, Tim C. Clayton, Rod Stables, Keith G. Oldroyd, Nick P. Curzen, David Hildick‐Smith · 2012 · Heart
  37. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry
    Iva Golemi, Lauren P. Cote, Omer Iftikhar, Benjamin Brenner, Alfonso Javier Tafur, Behnood Bikdeli, Carmen Fernández‐Capitán, José María Pedrajas, Remedios Otero, Roberto Quintavalla et al. · 2019 · Journal of Vascular Surgery Venous and Lymphatic Disorders
  38. The Value of Procalcitonin, a Novel Inflammatory Marker, in the Diagnosis of Myocardial Infarction and Evaluation of Acute Coronary Syndrome Patients
    Fırat Bektaş, Seçgin Söyüncü, İlker Gündüz, İbrahim Başarıcı, Halide S Akbas, Cenker Eken · 2010 · Journal of Emergency Medicine
  39. Clinical phenomapping and outcomes after heart transplantation
    Maral Bakir, NICHOLAS J. JACKSON, Simon Han, Alex A. T. Bui, Eleanor Chang, David A. Liem, Abbas A. Ardehali, Reza Ardehali, Arnold S. Baas, Marcella Calfon Press et al. · 2018 · The Journal of Heart and Lung Transplantation
  40. Percutaneous coronary intervention or coronary artery bypass graft in left main coronary artery disease: a comprehensive meta-analysis of adjusted observational studies and randomized controlled trials
    Maurizio Bertaina, Ovidio DE FILIPPO, Mario Iannaccone, Antonio Colombo, Gregg W. Stone, Patrick W.J.C. Serruys, Massimo Mancone, Pierluigi Omedè, Federico Conrotto, Mauro Pennone et al. · 2018 · Journal of Cardiovascular Medicine
  41. Low Dose Rivaroxaban for Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis
    Can Chen, Yuanqing Kan, Zhenyu Shi, Daqiao Guo, Weiguo Fu, Yanli Li, Qianzhou Lv, Xiaoyu Li, Yi Si · 2021 · Frontiers in Pharmacology
  42. Statins in prevention of repeat revascularization after percutaneous coronary intervention—A meta-analysis of randomized clinical trials
    Zhi-Jiang Zhang, Qi Cheng, Guo‐Xin Jiang, Oscar C. Marroquin · 2009 · Pharmacological Research
  43. The Use of a Binary Composite Endpoint and Sample Size Requirement: Influence of Endpoints Overlap
    Josep Ramón Marsal, Ignacio Ferreira González, Sandra Bertran, Aída Ribera, Gaietà Permanyer-Miralda, David Garcia-dorado A, Guadalupe Gómez Melis · 2016 · American Journal of Epidemiology
  44. From batting average to wins above replacement to composite end points—refining clinical research using baseball statistical methods
    Kevin Joseph Anstrom, Eric L. Eisenstein · 2011 · American Heart Journal
  45. Drug-eluting stents versus bare-metal stents for acute coronary syndrome
    Joshua Buron Feinberg, Emil Eik Nielsen, Janette Greenhalgh, Juliet C. Hounsome, Naqash J Sethi, Sanam Safi, Christian Nyfeldt Gluud, Janus Christian Jakobsen · 2016 · Cochrane Database of Systematic Reviews
  46. Prognostic Role of High-sensitivity Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2 in Surgical Intensive Care Unit Patients Undergoing Non-cardiac Surgery
    Hyun Suk Yang, Mina Hur, Ahram Yi, Hanah Kim, Jayoun Kim · 2018 · Annals of Laboratory Medicine
  47. Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights
    Josep Ramón Marsal, Iratxe Urreta, Marimar Ubeda, Dimelza Osorio, Blanca Lumbreras, David Lora, Borja Manuel Fernandez-Felix, Gerard Oristrell, Eduard Ródenas‐Alesina, Lorena Herrador et al. · 2022 · Trials
  48. Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatment
    Annette Ladefoged de Thurah, Ina Trolle Andersen, Andreas Bugge Tinggaard, Anders Hammerich Riis, Josephine Therkildsen, Hans Erik Bøtker, Morten Bøttcher, Ellen‐Margrethe Hauge · 2020 · RMD Open
  49. Antithrombotic therapy for postinterventional management of peripheral arterial disease
    Daria Zavgorodnyaya, Tamara Knight, Mitchell J. Daley, Pedro G. Teixeira · 2020 · American Journal of Health-System Pharmacy
  50. Major Adverse Cardiovascular Events in Antidepressant Users Within Patients With Ischemic Heart Diseases
    Jae Hyun Kim, Yun‐Kyoung Song, Ha Young Jang, Ju‐Young Shin, Hae‐Young Lee, Yong Min Ahn, Jung Mi Oh, In‐Wha Kim · 2020 · Journal of Clinical Psychopharmacology
  51. Prognostic outcome of routine clinical noninvasive multidetector-row computed tomography coronary angiography in patients with suspected coronary artery disease: a 2-year follow-up study
    L. La Grutta, Giuseppe Runza, G. Gentile, Emanuela Russo, Giuseppe Lo Re, Massimo Galia, Tommaso Vincenzo Bartolotta, Valerio Alaimo, Roberto Malagò, Filippo Cademartiri et al. · 2011 · La radiologia medica
  52. Relationship between clopidogrel-related polymorphisms and variable platelet reactivity at 1 year: A cohort study from Han Chinese
    Xiaodong Wang, Yan Lai, Yu Luo, Xumin Zhang, Hua Zhou, Zi Ye, Jiani Tang, Xuebo Liu · 2016 · Journal of Research in Medical Sciences
  53. Adverse Cardiac Events and Mortality in Patients with Critical Limb Ischemia
    Joost P. Roijers, Yannick Sebastiaan Rakké, Niels C.J. Hopmans, Thijs M.G. Buimer, Gwan H. Ho, Hans G.W. de Groot, Eelco J. Veen, Jeroen Vos, Paul G.H. Mulder, Lijckle van der Laan · 2019 · Annals of Vascular Surgery
  54. Periodontitis and Other Risk Factors Related to Myocardial Infarction and Its Follow-Up
    Tania Seoane, Beatriz Bullón, Patricia Fernández Riejos, Juan Carlos García-Rubira, N Garcia-Gonzalez, Pablo Villar-Calle, José Luis Quiles, Maurizio Antonio Battino, Pedro Bullón · 2022 · Journal of Clinical Medicine
  55. Serial multiple biomarkers in the assessment of suspected acute coronary syndrome: multiple infarct markers in chest pain (MIMIC) study
    Stephen P J Macdonald, Yusuf Nagree, Daniel M Fatovich, Michael R. Phillips, Simon G.A. Brown · 2012 · Emergency Medicine Journal
  56. Early Exclusion of Major Adverse Cardiac Events in Emergency Department Chest Pain Patients: A Prospective Observational Study
    Yuk‐ki Leung, Nga-man Cheng, Cangel Pui-yee Chan, Anna So Youn Lee, Jeffrey Ka-tak Wong, Bryan Ping-Yen Yan, Anil Tejbhan Ahuja, Colin Alexander Graham, Timothy Hudson Rainer · 2017 · Journal of Emergency Medicine
  57. Incidence and risk of major adverse cardiovascular events in middle-aged patients with chronic kidney disease: a population-based cohort study
    Shiauyee Chen, Wen-Yen Hsu, Yen-Nung Lin, Chien-Yung Wang, Chien‐Hua Wu, Kwang‐Hwa Chang · 2019 · International Urology and Nephrology
  58. Efficacy and Safety of Ticagrelor Compared to Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis
    Haihong Wu, Xiuying Xiang, Dandan Li, Su Shen, Xingang Li · 2020 · Current Pharmaceutical Design
  59. The effect of different combinations of vascular, dependency and cognitive endpoints on the sample size required to detect a treatment effect in trials of treatments to improve outcome after lacunar and non-lacunar ischaemic stroke
    Stephen Makin, Fergus Doubal, Terence J. Quinn, Philip M. Bath, Martin S. Dennis, Joanna Marguerite Wardlaw · 2017 · European Stroke Journal
  60. Thrombolysis for acute upper extremity deep vein thrombosis
    Joshua Buron Feinberg, Emil Eik Nielsen, Janus Christian Jakobsen · 2016 · Cochrane Database of Systematic Reviews
  61. Risk of major adverse cardiovascular events associated with elevated low-density lipoprotein cholesterol in a population with atherosclerotic cardiovascular disease with and without type 2 diabetes: a UK database analysis using the Clinical Practice Research Datalink
    Christopher Ll. Morgan, Adeline Durand, Terry McCormack, Elizabeth Hughes, Thomas R. Berni, Raquel Lahoz · 2023 · BMJ Open
  62. Evidence for antioxidants consumption in the coronary blood of patients with an acute myocardial infarction
    Patrice Guérin, Edith Bigot‐Corbel, Thierry Patrice · 2012 · Journal of Thrombosis and Thrombolysis
  63. Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation
    Nayoung Han, Seung Hee Han, Yun-Kyoung Song, Myeong Gyu Kim, Yon Su Kim, In‐Wha Kim, Jung Mi Oh · 2017 · Therapeutics and Clinical Risk Management
  64. Real-world experience of extracranial carotid artery interventions for atherosclerotic disease during a 10-year period
    Konstantinos T. Spanos, Christos Karathanos, Vasileios A. Lachanas, Aikaterini Drakou, Konstantinos Stamoulis, Stylianos G. Koutsias, Athanasios D. Giannoukas · 2018 · International Angiology
  65. Biomarker evaluation as a potential cause of gender differences in obesity paradox among patients with STEMI
    Stefan Baumann, Johanna Koepp, Tobias Becher, Aydin Huseynov, Katharina Bosch, Michael Behnes, Christian Fastner, Ibrahim El‐Battrawy, Matthias Renker, Siegfried Lang et al. · 2015 · Cardiovascular revascularization medicine
  66. Interpretation of CVD risk predictions in clinical practice: Mission impossible?
    Ghizelda R. Lagerweij, Karel G.M. Moons, G. Ardine de Wit, Hendrik Koffijberg · 2019 · PLoS ONE
  67. A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
    Hang Ouyang, Xuehui Zeng, Chunlei Zhang, Song Linli, Jiarui Xu, Zhihui Hou, Siya Xie, Zheng Tao, Jincai He · 2021 · Journal of Cardiothoracic Surgery
  68. Granulocyte-colony stimulating factor for large anterior ST-elevation myocardial infarction: Rationale and design of the prospective randomized phase III STEM-AMI OUTCOME trial
    Felice Achilli, Cristina Malafronte, Francesca Cesana, Stefano Maggiolini, Ciro Mauro, Gaetano Maria De Ferrari, Laura Lenatti, Maurizio Tespili, Paola Pasqualini, Francesco Gentile et al. · 2015 · American Heart Journal
  69. Estrategia de revascularización invasiva en el síndrome coronario sin elevación del segmento ST. El debate continúa
    Julio E. Núñez, Juan Manuel Sanchís, Vicent Bodı́ · 2009 · Medicina Clínica
  70. Electrical storm is associated with impaired prognosis compared to ventricular tachyarrhythmias
    Michael Behnes, Julian Müller, Dominik Ellguth, Tobias Schupp, Gabriel Taton, Linda Reiser, Niko Engelke, Thomas Reichelt, Armin Bollow, Seung-Hyun Kim et al. · 2019 · International Journal of Cardiology
  71. Platelet Function Analyzer-200 P2Y Results Are Predictive of the Risk of Major Adverse Cardiac Events in Korean Patients Receiving Clopidogrel Therapy Following Acute Coronary Syndrome
    Hyeon‐Ho Lim, Shuhua Li, Gyu‐Dae An, Kwang‐Sook Woo, Kyeong‐Hee Kim, Jeong-Man Kim, Moo Hyun Kim, Jin‐Yeong Han · 2018 · Annals of Laboratory Medicine
  72. Raccomandazioni del GdS MM SIPMeL per l'uso dei biomarcatori cardiaci in NSTEMI. Parte seconda: evidenze nella diagnosi
    Lucia Malloggi, Piero Cappelletti, Marco Moretti, Francesca Veneziani, Massimiliano Luca Manno, Maria Aurora Burgio, Alessio Gamboni, Matteo Cassin, Elisabetta Stenner, Margherita Morandini et al. · 2021 · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine
  73. Easily applicable multiple testing procedures to improve the interpretation of clinical trials with composite endpoints
    Svenja Schüler, Annegret Mucha, Patrick Doherty, Meinhard Kieser, Geraldine Rauch · 2014 · International Journal of Cardiology
  74. Long-Term Outcomes in Patients with Incident Chronic Obstructive Pulmonary Disease after Acute Kidney Injury: A Competing-Risk Analysis of a Nationwide Cohort
    Che‐Hsiung Wu, Huang-Ming Chang, C H Wang, Likwang Chen, Liang-Wen Chen, Chun‐Fu Lai, Shuenn‐Wen Kuo, Hao‐Chien Wang, Vin‐Cent Wu · 2018 · Journal of Clinical Medicine
  75. Predictive Inflammation-related microRNAs for Cardiovascular Events Following Early-Onset Coronary Artery Disease
    Shayan Ziaee, Maryam Hosseindokht, Sara Cheraghi, Leyla Pourgholi, Amirhossein Ahmadi, Saeed Sadeghian, Seyed Hesameddin Abbasi, Tahereh Davarpasand, Mohammadali Boroumand · 2020 · Archives of Medical Research
  76. Clinical Features and Prognoses of Middle-Aged Women With ST-Elevation Myocardial Infarction With a Focus on Spontaneous Coronary Artery Dissection
    Aliasghar Almasi, Pejman Mansouri, Mana Jameie, Somayeh Yadangi, Saeed Haghighi Parapary, Seyed Abolfazl Mohsenizadeh, Peiman Jamshidi, Yaser Jenab · 2021 · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
  77. Trials using composite outcomes neglect the presence of competing risks: a methodological survey of cardiovascular studies
    Hyunwoo Kim, Hamad Shahbal, Sameer Parpia, Tauben Averbuch, Harriette G.C. Van Spall, Lehana Thabane, Jinhui Ma · 2023 · Journal of Clinical Epidemiology
  78. Cardiovascular implications of MASLD: overview of the evidence
    Belend Ismail, Puria Nabilou, Lise Lotte Gluud, Søren Møller · 2025 · Scandinavian Journal of Gastroenterology
  79. Add-on tests for improving risk-stratification in emergency department patients with chest pain who are at low to moderate risk of 30-day major adverse cardiac events
    Timothy Hudson Rainer, Yuk‐ki Leung, Anna So Youn Lee, P.Y. Chan, Nga-man Cheng, J.K. Wong, B.P.Y. Yan, Anil Tejbhan Ahuja, Colin Alexander Graham · 2016 · International Journal of Cardiology
  80. The Effect of CYP2C19 and Nongenetic Factors on Clopidogrel Responsiveness in the MENA Region: A Systematic Review
    Zainab Omer Ali, Hazem Fathy Elewa · 2019 · Clinical and Applied Thrombosis/Hemostasis
  81. Preexisting right ventricular systolic dysfunction in high-risk patients undergoing non-emergent open abdominal surgery
    Jody Chou, Michael W. Ma, Maryte Gylys, Nicolas A. Salvatierra, Robert Kim, Ailin Barseghian, Joseph B. Rinehart · 2021 · Annals of Cardiac Anaesthesia
  82. Electrical storm reveals worse prognosis compared to myocardial infarction complicated by ventricular tachyarrhythmias in ICD recipients
    Julian Müller, Michael Behnes, Tobias Schupp, Dominik Ellguth, Gabriel Taton, Linda Reiser, Niko Engelke, Martin Borggrefe, Thomas Reichelt, Armin Bollow et al. · 2021 · Heart and Vessels
  83. Patients with periodontitis and erectile dysfunction suffer a greater incidence of major adverse cardiovascular events: A prospective study in a Spanish population
    Francisco Mesa, Miguel Angel Arrabal‐Polo, Antonio Magán‐Fernández, Miguel Arrabal, Amada Martin, Ricardo Muñoz, Alejandro Rodriguez‐Agurto, Manuel Bravo · 2021 · Journal of Periodontology
  84. Electrocardiogram interpretation during nurse triage improves the performance of the triage system in patients with cardiovascular symptoms – A prospective observational study
    Arian Zaboli, Dietmar Ausserhofer, Serena Sibilio, Elia Toccolini, Rupert Paulmichl, Alberto Giudiceandrea, Antonio Bonora, Norbert Pfeifer, Gianni Turcato · 2023 · International Emergency Nursing
  85. Attitudes to outcomes measured in clinical trials of cardiovascular prevention
    Michelle D. Canavan, Andrew Smyth, S.M. Robinson, Irene Gibson, C. Costello, Shaun T. O’Keeffe, T. Walsh, E. C. Mulkerrin, Martin James O'Donnell · 2015 · QJM
  86. Cessation of dual antiplatelet therapy and cardiovascular events following acute coronary syndrome
    Wardati Mazlan‐Kepli, Jesse Dawson, Colin Berry, James Walters · 2018 · Heart
  87. Accuracy of triggering receptor expressed on myeloid cells 1 in diagnosis and prognosis of acute myocardial infarction: a prospective cohort study
    Zhenjun Ji, Rui Zhang, Mingming Yang, Wenjie Zuo, Yuyu Yao, Yangyang Qu, Yamin Su, Zhuyuan Liu, Ziran Gu, Genshan Ma · 2021 · PeerJ
  88. Dynamic effects of COVID-19 vaccination on major acute cardiovascular events and mortality following SARS-CoV-2 infection in a target trial emulation study
    Tatjana Meister, Ülo Maiväli, Kaur Tenson, Anna Tisler, Ruth Kalda, Kadri Suija, Anneli Uusküla · 2025 · Scientific Reports
  89. Outcome measures for randomised clinical trials and multicentre observational studies of cardiovascular diseases published in major clinical journals: systematic review and evidence mapping
    Asad Bhatty, Chris Wilkinson, Suleman Aktaa, Gorav Batra, Benjamin Beska, Phyo H Khaing, Ali Wahab, Keerthenan Raveendra, Ahmed Taha, Ramesh Nadarajah et al. · 2025 · Heart
  90. Comparison of coronary artery bypass graft versus drug-eluting stents in dialysis patients: an updated systemic review and meta-analysis
    Narut Prasitlumkum, Wisit Cheungpasitporn, Ryota Sato, Sittinun Thangjui, Charat Thongprayoon, Jakrin Kewcharoen, Tarun Jacob Bathini, Saraschandra Vallabhajosyula, Supawat Ratanapo, Ronpichai Chokesuwattanaskul · 2021 · Journal of Cardiovascular Medicine
  91. Insuficiencia cardiaca en el seno de un síndrome coronario agudo como predictor de infarto a largo plazo
    N. Cháfer, Patricia Palau, Julio E. Núñez, Gema Miñana, R. Sanjuán, Juan Manuel Sanchís · 2011 · Revista Clínica Española
  92. Clinical impact of routine follow-up coronary angiography after second- or third-generation drug-eluting stent insertion in clinically stable patients
    Seonghoon Choi, Hee-Sun Mun, Min‐Kyung Kang, Jung Rae Cho, Seong Woo Han, Namho Lee · 2015 · The Korean Journal of Internal Medicine
  93. Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease
    Maria Dorobanţu, Nicoleta‐Monica Popa‐Fotea, Mihaela Octavia Popa, Iulia Rusu, Miruna Mihaela Micheu · 2017 · World Journal of Stem Cells
  94. Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure
    Fiona Ryan, Cristín A. Ryan, Mark T. Ledwidge, Kenneth McDonald, Chris J Watson, Ciara Keane, Joe Gallagher · 2018 · Cochrane Database of Systematic Reviews
  95. The Year in Interventional Cardiology
    Simon R. Dixon, Cindy Lee Grines, William W. O’Neill · 2009 · Journal of the American College of Cardiology
  96. Clinical outcome prediction using observational supervision with electronic health records and audit logs
    Nandita Bhaskhar, Wui Ip, Jonathan H. Chen, Daniel L. Rubin · 2023 · Journal of Biomedical Informatics
  97. Pre-Dialysis Visits to a Nephrology Department and Major Cardiovascular Events in Patients Undergoing Dialysis
    Chih‐Yuan Huang, Chia‐Wen Hsu, Chi-Rou Chuang, Ching‐Chih Lee · 2016 · PLoS ONE
  98. Stress Perfusion Cardiac Magnetic Resonance in Long-Standing Non-Infarcted Chronic Coronary Syndrome with Preserved Systolic Function
    Pierpaolo Palumbo, Ester Cannizzaro, Annamaria Di Cesare, Federico Bruno, Francesco Arrigoni, Alessandra Splendiani, Antonio Barile, Carlo Masciocchi, Ernesto Di Cesare · 2022 · Diagnostics
  99. Predictive Factors for Major Adverse Cardiac and Cerebrovascular Events in Octogenarians after Elective Endovascular Aneurysm Repair
    Yinzhi Shen, Yuhan Qi, Jichun Zhao, Bin Huang, Ding Yuan, Tiehao Wang, Jiarong Wang · 2022 · Annals of Vascular Surgery
  100. First and recurrent events after percutaneous coronary intervention: implications for survival analyses
    Anupama Vasudevan, James W. Choi, Georges A. Feghali, Aaron Y. Kluger, Stuart R. Lander, Kristen M. Tecson, Mohanakrishnan Sathyamoorthy, JEFFREY M. SCHUSSLER, Robert Stoler, Ravi C. Vallabhan et al. · 2019 · Scandinavian Cardiovascular Journal